In comparison with hUCMSCs, SIRT1-modified hUCMSCs might improve the paracrine and posttranscriptional modification that have a synergistic effect with hUCMSCs on TGF-β signaling inhibition in peritoneal fibrosis. The gene discussed is TGFB1; the disease is Peritoneal Fibrosis.